• Publications
  • Influence
The staphylococcal scalded-skin syndrome.
Abstract A syndrome of dermatologic response to infection with phage Group 2 coagulase-positive staphylococci with reactions ranging from bullous impetigo to generalized scarlatiniform rash withoutExpand
  • 320
  • 5
Characterization of T cell repertoire changes in acute Kawasaki disease
Kawasaki disease (KD) is an acute multisystem vasculitis of unknown etiology that is associated with marked activation of T cells and monocyte/macrophages. Using a quantitative polymerase chainExpand
  • 192
  • 5
  • PDF
Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease.
  • J. Abe, B. Kotzin, +4 authors D. Leung
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences…
  • 1 May 1992
Kawasaki disease (KD) is an acute vasculitis complicated by the development of coronary artery abnormalities. The etiology of KD is unknown. Based on the observation that KD is associated with markedExpand
  • 314
  • 4
Mucocutaneous lymph node syndrome in the United States.
Sixteen patients with an unusual and distinct symptom complex were encountered during a four-year period. Principal features of this syndrome are (1) fever lasting more than seven days; (2)Expand
  • 208
  • 3
Association of Kawasaki disease with tropospheric wind patterns
The causal agent of Kawasaki disease (KD) remains unknown after more than 40 years of intensive research. The number of cases continues to rise in many parts of the world and KD is the most commonExpand
  • 117
  • 3
  • PDF
Congenital cytomegalovirus infection. Developmental progress of infants detected by routine screening.
Cytomegalovirus (CMV) infection was detected in 22 of 3,808 newborns using two survey methods. Of 1,963 urine specimens cultured for virus, 20 (1%) were positive. One child had moderately severeExpand
  • 104
  • 2
Infliximab treatment for refractory Kawasaki syndrome.
OBJECTIVE To evaluate the use of tumor necrosis factor (TNF)-alpha blockade for treatment of patients with Kawasaki syndrome (KS) who fail to become afebrile or who experience persistent arthritisExpand
  • 154
  • 2
Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease.
OBJECTIVE To investigate the safety, tolerability, and pharmacokinetics of the anti-tumor necrosis factor-alpha monoclonal antibody infliximab in subjects with intravenous immunoglobulinExpand
  • 159
  • 2
Kawasaki syndrome: an update.
Fifteen years' experience with this “new” multisystem disease of very young children has led to a broader understanding of its clinical behavior, pathology, epidemiology, and spectrum of associatedExpand
  • 39
  • 2
Epstein-Barr virus and other herpesvirus infections in Kawasaki syndrome.
Epstein-Barr virus (EBV), a possible cause of Kawasaki syndrome (KS), is not pathenogenically associated with KS in Hawaii. The prevalence of EBV capsid antibody in KS patients was found not toExpand
  • 41
  • 2